Plasma homocysteine levels in children and adolescents with type 1 diabetes

Indian Pediatrics

Volumn 43, Issue 5, 2006, Pages 401-407

  Atabek, Mehmet Emre ^a   Pirgon, Ozgur ^a   Karagozoglu, Emrah ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Folate; Homocysteine; Type 1 diabetes; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; VITAMIN BLOOD LEVEL;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HOMOCYSTEINE; HUMANS; MALE;

EID: 33744501882     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-527.
2. Barton P, Malinow MR. Homocystinemia and risk of atherosclerosis: a clinical approach to evaluation and management. Endocrinologist 1998; 8: 170-177.
3. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
4. Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schafer EJ, Malinow MR. Prevalence of familial hyperhomocystinemia in men with premature coronary artery disease. Atherioscler Thromb 1991; 11: 1129-1136.
5. Hultberg B, Agardh E, Andersson A, Brattstrom L , Isaksson A, Israelsson B, Agardh CD. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Invest 1991; 51: 277-282.
6. Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocystinemia and endothelial dysfunction in IDDM. Diabetes Care 1998; 21: 841-848.
7. Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in japanese patients with type 2 diabetes. Diabetes Care 1999; 22: 484-490.
8. Cronin CC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG. Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 1998; 21: 1843-1847.
9. Reddy MN. Reference ranges for total homocysteine in children. Clin Chim Acta 1997;262:153-155.
10. Osganian SK, Stampfer MJ, Spiegelman D, et al. Distribution of and factors associated with serum homocysteine levels in children. Child and adolescent trial for cardiovascular health. JAMA 1999; 281: 1189-1196.
11. Ueland PM, Refsum H, Stabler SP, Malinow MR, Anderson A, Allen RH. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993; 39: 1764-1779.
12. Vilaseca MA, Moyano D, Artuch R, et al. Selective screening for hyperhomocysteinemia in pediatric patients. Clin Chem 1998; 44: 662-664.
13. Pavia C, Ferrer I, Valls C, Artuch R, Colome C, Vilaseca MA. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000; 23: 84-87.
14. Wiltshire E, Thomas DW, Baghurst P, Couper J. Reduced total plasma homocystine in children and adolescents with type 1 diabetes. J Pediatr 2001;138: 888-893.
15. Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, et al. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects. Diabetologi 44: 979-982.
16. Agardh E, Hultberg B, Agardh CD. Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine. Scand J Clin Lab Invest. 2000; 60: 169-174.
17. Targher G, Bertolini L, Zenari L, Cacciatori V, Muggeo M, Faccini G, et al. Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care 2000; 23: 524-528.
18. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998; 97: 437-443.
19. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698.
20. Wilson PW, Jacques PF. Epidemiology of homocysteine levels and relation to vitamins. In: Robinson K, ed. Homocysteine and Vascular Disease. The Netherlands: Kluwer Academic Publishers 2000. p 85-95.
21. Hultberg B, Agardh CD, Agardh E, Lovestam-Adrian M. Poor metabolic control, early age at onset, and marginal folate deficiency a reassociated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus: a five-year follow-up study. Scand J Clin Lab Invest 1997; 57: 595-600.
22. Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 1997; 349: 473-474.
23. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
24. Nutrition Coordinating Center. Food Database Version 5A: Nutrient Data Base Version 20. Minneapolis, MN: University of Minneosota, 1991.
25. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995;116:59-62.
26. Chico A, Blanco F, Córdoba A, Pérez A: Hiperhomocisteinemia moderada yriesgo arteriosclerótico. Endocrinología 1996; 43: 329-331.
27. Skinner AM, Addison GM, Price DA. Changes in the urinary excretion of creatinine, albumin and N-acetyl-beta-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 1996; 155: 596- 602.